Lupin inks pact to acquire 5 drug brands from Menarini for Rs 101 crore

Lupin said it has inked a pact to acquire five drug brands from Italian firm Menarini for Rs 101 crore. The company has signed an agreement to acquire five legacy brands catering to gastroenterology, urology and anti-infective segments, the Mumbai-based company said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9LCxSEo
via IFTTT